Not Yet RecruitingACTRN12622001468718
Official study titleFeasibility of integrating the “Cogito” therapy-homework smartphone app to metacognitive training for people with psychosis; a pilot trial.
This study isn't recruiting yet.
In Noarlunga CentreSchizophreniaInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Flinders University
Not Yet RecruitingACTRN12626000914369
Official study titlePilot of a novel co-produced supported and shared decision-making model relating to medication for early psychosis (Choices)
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 12–25
- Countries
- Australia
- Sponsor
- Orygen
Not Yet RecruitingACTRN12617000730303
Official study titleHealth service use of clients after discharge from an Early Intervention in Psychsosis service
This study isn't recruiting yet.
In New ZealandSchizophreniaObservational studyAges 15–36
- Countries
- New Zealand
- Sponsor
- Capital & Coast District Health Board, Wellington Early Intervention in Psychosis Service
RecruitingNCT06540833
Official study titleA Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI 1284 in Patients With Psychosis Associated With Alzheimer's Disease
Multiple locations, including AnaheimSchizophreniaMedication studyAges 55+
- Countries
- United States, Bulgaria, Croatia, + 7 others
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT05142735
Official study titleEffects of N-acetylcysteine on Psychosis-like Symptoms and a Neurophysiological Biomarker of the Clinical High Risk for Schizophrenia
In TorontoSchizophreniaPlacebo comparisonAges 16–35
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
RecruitingNCT05973110
In OttawaSchizophreniaBehavioural studyAges 18–60
- Countries
- Canada
- Sponsor
- The Royal Ottawa Mental Health Centre
RecruitingNCT05813457
Official study titleImpact of an Early Identification Program for First-Episode Psychosis on the Duration of Untreated Psychosis. Multicenter, Randomized Stepped-wedge Study
Multiple locations, including BronSchizophreniaInterventional studyAges 15–35
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
RecruitingNCT07680114
Official study titleA Pilot Feasibility Study of Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
In MadisonSchizophreniaDevice studyAges 18–50
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
RecruitingNCT07098169
Official study titleRandomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
Multiple locations, including San DiegoSchizophreniaBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- University of California, San Diego
Not Yet RecruitingNCT07025499
This study isn't recruiting yet.
In HamiltonSchizophreniaBehavioural studyAges 18+
- Countries
- Canada
- Sponsor
- McMaster University
RecruitingISRCTN44794154
In NigeriaSchizophreniaResearch studyAges 18–30
- Countries
- Nigeria
- Sponsor
- Lagos State University College of Medicine
Not Yet RecruitingACTRN12621001222831
Official study titleRemission rates and cost-effectiveness of Pharmaco-genetic testing and academic detailing in adults with depression and psychosis in a public mental health service
This study isn't recruiting yet.
Multiple locations, including Bedford ParkSchizophrenia, Depression, ...Interventional studyAges 18–70
- Countries
- Australia
- Sponsor
- Flinders University of South Australia
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.